Prognostication Based on Texture Analysis of Baseline 18F Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Nonsmall-Cell Lung Carcinoma Patients Who Underwent Platinum-Based Chemotherapy as First-Line Treatment

Line Treatment ◽

First Line ◽

Cell Lung Carcinoma ◽

Positron Emission ◽

Platinum Based Chemotherapy ◽

Fluorodeoxyglucose Positron Emission ◽

HD15 for advanced stage Hodgkin's disease: Quality assurance protocol for reduction of toxicity and the prognostic relevance of fluorodeoxyglucose-positron-emission tomography (FDG-PET) in the first-line treatment of advanced stage Hodgkin's disease

http://isrctn.org/> ◽

10.1186/isrctn32443041 ◽

2013 ◽

Author(s):

Volker Diehl

Keyword(s):

Hodgkin's Disease ◽

Hodgkin’S Disease ◽

Emission Tomography ◽

Advanced Stage ◽

Line Treatment ◽

First Line ◽

Positron Emission ◽

Fluorodeoxyglucose Positron Emission ◽

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma

Cancer ◽

10.1002/1097-0142(20010815)92:4<886::aid-cncr1397>3.0.co;2-v ◽

2001 ◽

Vol 92 (4) ◽

pp. 886-895 ◽

Cited By ~ 153

Author(s):

Michael P. Mac Manus ◽

Rodney J. Hicks ◽

David L. Ball ◽

Victor Kalff ◽

Jane P. Matthews ◽

...

Keyword(s):

Lung Carcinoma ◽

Emission Tomography ◽

Radical Radiotherapy ◽

Cell Lung Carcinoma ◽

Positron Emission ◽

Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study

Annals of Thoracic Medicine ◽

10.4103/1817-1737.165296 ◽

2016 ◽

Vol 11 (1) ◽

pp. 49 ◽

Cited By ~ 3

Author(s):

NghiC Nguyen ◽

Kumar Abhishek ◽

Samuel Nyon ◽

Hussein RabieS Farghaly ◽

MedhatM Osman ◽

...

Keyword(s):

Computed Tomography ◽

Lung Carcinoma ◽

Emission Tomography ◽

Cell Lung Carcinoma ◽

Positron Emission ◽

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

Cancer ◽

10.1002/(sici)1097-0142(19980901)83:5<918::aid-cncr17>3.0.co;2-y ◽

1998 ◽

Vol 83 (5) ◽

pp. 918-924 ◽

Cited By ~ 213

Author(s):

Vinita Ahuja ◽

R. Edward Coleman ◽

James Herndon ◽

Edward F. Patz

Keyword(s):

Prognostic Significance ◽

Positron Emission Tomography Imaging ◽

Emission Tomography ◽

Cell Lung Carcinoma ◽

Tomography Imaging ◽

Positron Emission ◽

How does positron emission tomography-adapted therapy as first-line treatment affect outcomes in people with early-stage Hodgkin lymphoma?

Cochrane Clinical Answers ◽

10.1002/cca.758 ◽

2015 ◽

Author(s):

Simona Nistor-Grahl

Keyword(s):

Hodgkin Lymphoma ◽

Early Stage ◽

Emission Tomography ◽

Line Treatment ◽

First Line ◽

Positron Emission ◽

F-18 fluorodeoxyglucose positron emission tomography in the mediastinal nodal staging of non-small cell lung carcinoma

Lung Cancer ◽

10.1016/s0169-5002(00)80839-9 ◽

2000 ◽

Vol 29 (1) ◽

pp. 245-246

Author(s):

S.U Berlangieri ◽

A.M Scott ◽

P Mitchell ◽

S Knight ◽

G.J Fitt ◽

...

Keyword(s):

Small Cell Lung Carcinoma ◽

Small Cell ◽

Emission Tomography ◽

Nodal Staging ◽

Small Cell Lung ◽

Cell Lung Carcinoma ◽

Positron Emission ◽

Can positron emission tomography with [18 F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

British Journal of Haematology ◽

10.1046/j.1365-2141.2001.03169.x ◽

2001 ◽

Vol 115 (2) ◽

pp. 272-278 ◽

Cited By ~ 137

Author(s):

Karoline Spaepen ◽

Sigrid Stroobants ◽

Patrick Dupont ◽

José Thomas ◽

Peter Vandenberghe ◽

...

Keyword(s):

Hodgkin's Disease ◽

Hodgkin’S Disease ◽

Emission Tomography ◽

Line Treatment ◽

First Line ◽

Positron Emission ◽

Additional Therapy ◽

Oral Versus Intravenous Administration of Vinorelbine as a Single Agent for the First-Line Treatment of Metastatic Nonsmall Cell Lung Carcinoma (NSCLC)

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000256103.21797.e5 ◽

2007 ◽

Vol 30 (3) ◽

pp. 245-251 ◽

Cited By ~ 14

Author(s):

Vera Hirsh ◽

Pierre Desjardins ◽

Burton M. Needles ◽

James R. Rigas ◽

Mohammad Jahanzeb ◽

...

Keyword(s):

Lung Carcinoma ◽

Intravenous Administration ◽

Single Agent ◽

Line Treatment ◽

First Line ◽

Cell Lung Carcinoma ◽

First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine

Cancer ◽

10.1002/(sici)1097-0142(19981115)83:10<2083::aid-cncr6>3.0.co;2-i ◽

1998 ◽

Vol 83 (10) ◽

pp. 2083-2090 ◽

Cited By ~ 38

Author(s):

Charalambos Kourousis ◽

Nicos Androulakis ◽

Stelios Kakolyris ◽

John Souglakos ◽

George Maltezakis ◽

...

Keyword(s):

Lung Carcinoma ◽

Line Treatment ◽

First Line ◽

Cell Lung Carcinoma ◽

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)

Cancer ◽

10.1002/cncr.21495 ◽

2005 ◽

Vol 104 (12) ◽

pp. 2766-2774 ◽

Cited By ~ 112

Author(s):

Chandra P. Belani ◽

Frank Fossella

Keyword(s):

Lung Carcinoma ◽

Subgroup Analysis ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Cell Lung Carcinoma ◽

Phase Iii Study ◽